Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 2,281-2,292 of 10,612
Drug study icon
Active Not RecruitingNCT06741228

Study of DT120 for Generalized Anxiety Disorder (Voyage)

This study is active but not recruiting in the United States. It focuses on anxiety.

In United States
AnxietyDrugA study involving a medication or substance.From 18 Years to 74 Years
Countries
United States
Sponsor
Definium Therapeutics US, Inc.
Condition
Anxiety
Drug study icon
Active Not RecruitingNCT06941844

Study of DT120 for Major Depressive Disorder (Emerge)

This study is active but not recruiting in the United States. It focuses on depression.

In United States
DepressionDrugFrom 18 Years to 74 Years
Countries
United States
Sponsor
Definium Therapeutics US, Inc.
Condition
Depression
Drug study icon
Active Not RecruitingNCT06809595

Study of MM120 for Generalized Anxiety Disorder (Panorama)

This study is active but not recruiting in the United States, in France, in the United Kingdom, .... It focuses on anxiety.

In United States
AnxietyDrugFrom 18 Years to 74 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Definium Therapeutics US, Inc.
Condition
Anxiety
Drug study icon
CompletedNCT02873208

Safety study of ALKS 3831 in schizophrenia

This study is completed in the United States. It is testing ALKS 3831 for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Alkermes, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00277212

Safety and Efficacy of Aripiprazole for Bipolarity

This study is completed in the United States. It is testing safety and Efficacy of Aripiprazole for Bipolarity.

In United States
BipolarityDrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT01452919

A Physical Dependence Study in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Greece
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.